Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Zealand Pharma - Filing #5889383

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
1,083,445,000 DKK
708,865,000 DKK
Revenue
62,691,000 DKK
342,788,000 DKK
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
930,816,000 DKK
425,668,000 DKK
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
7,332,915,000 DKK
1,094,033,000 DKK
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
8,288,491,000 DKK
907,014,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.